Home

Insights

PE

Bharat Parenterals Ltd P/E Ratio

Bharat Parenterals Ltd P/E Ratio

download
stocks purchased

₹ 0.0 Cr

Volume transacted

stocks purchased

0.3 K

stocks traded

Last Updated time: 13 Jul 15:30 PM

Image

Bharat Parenterals Ltd

NSE: BHARATPARENTER

PE

62.9

Last updated : 13 Jul 15:30 PM

Key Highlights

    The P/E Ratio of Bharat Parenterals Ltd is 62.9 as of 13 Jul 15:30 PM .a1#The P/E Ratio of Bharat Parenterals Ltd changed from 5.9 on March 2019 to 45 on March 2024 . This represents a CAGR of 40.30% over 6 years. a1#The Latest Trading Price of Bharat Parenterals Ltd is ₹ 1586 as of 12 Jul 15:30 .a1#The PE Ratio of Pharmaceuticals Industry has changed from 28.5 to 27.2 in 5 years. This represents a CAGR of -0.93%a1# The PE Ratio of Automobile industry is 17.2. The PE Ratio of Finance industry is 24.7. The PE Ratio of IT - Software industry is 29.2. The PE Ratio of Pharmaceuticals industry is 37.5. The PE Ratio of Retail industry is 143.1. The PE Ratio of Textiles industry is 12.1. In 2024a1#The Market Cap of Bharat Parenterals Ltd changed from ₹ 126.05 crore on March 2019 to ₹ 648.03 crore on March 2024 . This represents a CAGR of 31.37% over 6 years. a1#The Revenue of Bharat Parenterals Ltd changed from ₹ 27.63 crore to ₹ 70.46 crore over 8 quarters. This represents a CAGR of 59.69% a1#The EBITDA of Bharat Parenterals Ltd changed from ₹ 3.35 crore to ₹ 3.64 crore over 8 quarters. This represents a CAGR of 4.24% a1#The Net Pr of Bharat Parenterals Ltd changed from ₹ 1.12 crore to ₹ -2.56 crore over 8 quarters. This represents a CAGR of NaN% a1#The Dividend Payout of Bharat Parenterals Ltd changed from 1.78 % on March 2019 to 2.58 % on March 2024 . This represents a CAGR of 20.39% over 2 years. a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

×

Historical P/E Ratio of Bharat Parenterals Ltd

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Historical P/E Ratio of Bharat Parenterals Ltd

Period
Mar '195.9
Mar '203.4
Mar '219.4
Mar '229.4
Mar '2311.8
Mar '2445

Company Fundamentals for Bharat Parenterals Ltd

Market Cap

916 Cr

EPS

25.2

P/E Ratio (TTM) *

62.9

P/B Ratio (TTM) *

4.6

Day’s High

1657.0

Day’s Low

1555.0

DTE *

0.8

ROE *

7.4

52 Week High

1824.7

52 Week Low

417.05

ROCE *

6.2

* All values are consolidated

Last Updated time: 13 Jul 15:30 PM

* All values are consolidated

Last Updated time: 13 Jul 15:30 PM

Image

Bharat Parenterals Ltd

NSE: BHARATPARENTER

PRICE

1586.25

6.25 (0.40%)

stock direction

Last updated : 12 Jul 15:30

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

SWOT Analysis Of Bharat Parenterals Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

Asset Value vs Market Value of Bharat Parenterals Ltd

Market Value

916

Asset Value

261

2.5 X

Value addition

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Bharat Parenterals Ltd62916
Sun Pharmaceuticals Industries Ltd37378,675
Cipla Ltd28122,093
Divis Laboratories Ltd75120,480
Zydus Lifesciences Ltd30118,217
Dr Reddys Laboratories Ltd20112,137

Key Valuation Metric of Bharat Parenterals Ltd

Earnings

14 Cr

62.9 X

PE Ratio

Market Cap

₹916.01Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Earnings

14 Cr

62.9 X

PE Ratio

Market Cap

₹916.01Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

×

Historical Market Cap of Bharat Parenterals Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of Bharat Parenterals Ltd

Period
Mar '19126
Mar '2081
Mar '21192
Mar '22197
Mar '23194
Mar '24648

* All values are a in crore

×

Historical Revenue of Bharat Parenterals Ltd

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Historical Revenue of Bharat Parenterals Ltd

Period
Jun '2228
Sep '2288
Dec '2263
Mar '2351
Jun '2372
Sep '2362
Dec '2361
Mar '2470

* All values are a in crore

×

Historical EBITDA of Bharat Parenterals Ltd

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

Historical EBITDA of Bharat Parenterals Ltd

Period
Jun '223
Sep '2216
Dec '226
Mar '237
Jun '2313
Sep '237
Dec '238
Mar '244

* All values are a in crore

×

Historical Net Profit of Bharat Parenterals Ltd

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Historical Net Profit of Bharat Parenterals Ltd

Period
Jun '221
Sep '2210
Dec '222
Mar '232
Jun '237
Sep '232
Dec '234
Mar '24-3

* All values are a in crore

×

Historical Dividend Payout of Bharat Parenterals Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Bharat Parenterals Ltd

Period
Mar '190
Mar '200
Mar '210
Mar '220
Mar '232
Mar '243

* All values are a in %

About Bharat Parenterals Ltd

About Bharat Parenterals Ltd

    Bharat Parenterals Ltd. was incorporated on Sep.'92 in Gujarat and promoted by Ramesh Desai and Bharat Desai. The Company is engaged in the business of manufacturing drugs, pharmaceutical formulations and ayurvedic products at its plant in Baroda. It has set-up a fully integrated and modern plant as per WHO standards at Haripura near Baroda for manufacturing pharmaceutical formulations, life saving drugs, parenterals and antibiotics. In 2016, Varenyam Healthcare Private Limited was incorporated as wholly owned subsidiary company effective 09 July, 2016. Innoxel Lifesciences was incorporated as wholly owned subsidiary company effective 16th October, 2020. Varenyam Biolifesciences got incorporated as wholly owned subsidiary company effective 28th June, 2022.

Bharat Parenterals Ltd News Hub

News

Bharat Parenterals schedules AGM

Bharat Parenterals announced that the Annual General Meeting (AGM) of the company will be ...

Read more

12 Jun 202410:01

News

Bharat Parenterals to hold board meeting

Bharat Parenterals will hold a meeting of the Board of Directors of the Company on 10 June...

Read more

07 Jun 202410:29

News

Bharat Parenterals schedules board meeting

Bharat Parenterals will hold a meeting of the Board of Directors of the Company on 5 June ...

Read more

27 May 202417:42

News

Board of Bharat Parenterals recommends final dividend

Bharat Parenterals announced that the Board of Directors of the Company at its meeting hel...

Read more

23 May 202411:09

News

Bharat Parenterals schedules board meeting

Bharat Parenterals will hold a meeting of the Board of Directors of the Company on 22 May ...

Read more

11 May 202411:41

News

Bharat Parenterals EGM scheduled

Bharat Parenterals announced that an Extra Ordinary General Meeting (EGM) of the Company w...

Read more

30 Apr 202410:46

Product Composition by Percentage (Revenue)

FAQs for PE of Bharat Parenterals Ltd

What is Bharat Parenterals Ltd current share price?

The current market price of Bharat Parenterals Ltd as of July 13, 2024 is ₹1586.25.

What is Bharat Parenterals Ltd's market cap?

Bharat Parenterals Ltd's market capitalisation stood at ₹916 Cr as of July 13, 2024

What are Bharat Parenterals Ltd's total net assets?

According to Bharat Parenterals Ltd's most recent financial filings, the company's net assets total ₹261.4 Cr.

Is Bharat Parenterals Ltd making a profit or loss?

Bharat Parenterals Ltd's net Profit as of July 13, 2024 is close to ₹14 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199